Zepbound 2.5 MG/0.5 ML pen 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26FM6T3
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $65,615
Award facts
- Contract value 100% obligated
- $65,615.47 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $65,615.47 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Zepbound 2.5 mg/0.5 ml pen injections (0.5 ml) on December 12, 2025, with an ultimate completion date of December 15, 2025. This is a non-set-aside award executed through open competition. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026, which enables the contractor to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal medical procurement vendor for the Defense Logistics Agency and supporting military and veteran healthcare systems. The company's federal contracting portfolio demonstrates extensive experience fulfilling diverse pharmaceutical delivery orders, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This award supports DLA's medical supply chain operations and aligns with the agency's broader strategy for pharmaceutical prime vendor programs, which includes plans for multiple regional contractor awards to ensure comprehensive global pharmaceutical support for the Department of Defense healthcare ecosystem.
Quick answers
Who was awarded contract SPE2DR26FM6T3?
SPE2DR26FM6T3 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 12, 2025.
How much is contract SPE2DR26FM6T3 worth?
The government has obligated $65,615 on SPE2DR26FM6T3.
Is contract SPE2DR26FM6T3 an order under another contract?
Yes. SPE2DR26FM6T3 is a delivery order under SPE2DR25D2211, an indefinite delivery contract.
Was contract SPE2DR26FM6T3 competed?
The extent of competition for SPE2DR26FM6T3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award